Results 141 to 150 of about 5,052,415 (279)

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; July 2022

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Inpatient Exposure, Confidence, and Knowledge in Pediatric Hematology/Oncology: Evaluating General Pediatric Residents During 2025 ACGME Curriculum Change

Pediatric Blood &Cancer, Volume 73, Issue 9, September 2026.
ABSTRACT Background General pediatricians often evaluate hematologic and oncologic presentations before subspecialty consultation, yet the 2025 Accreditation Council for Graduate Medical Education (ACGME) pediatric requirements reduce inpatient pediatric hematology/oncology (PHO) time, raising questions about resident readiness.
Colburn Yu, Rohini Jain
wiley   +1 more source

Therapeutic potential of haptoglobin in a murine model of sickle cell anemia. [PDF]

PLoS One
Dos Santos BC, Dos Santos MNN, Pedroso GA, de Oliveira BB, de Albuquerque DM, de Oliveira NR, Noronha DC, Costa FF, Corat MAF.   +8 more
europepmc   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; November 2022

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Charting Morphotoxicity With Complementary Embryo Models

Advanced Healthcare Materials, Volume 15, Issue 35, 18 September 2026.
Three human embryo models of the peri‐implantation stages are exposed to a library of compounds. The (toxic) effects of the compounds are analyzed through automated image analysis pipelines. By evaluating the differential responses of the embryo models, this study underscores the importance of testing complementary embryo models to achieve robust and ...
Dorian G. Luijkx, Pauline L. Balder, Romy M. L. Verhagen, Vinidhra Shankar, Barry Jutten, Pinak Samal, Timo Rademakers, Clemens A. van Blitterswijk, Stefan Giselbrecht, Erik J. Vrij   +9 more
wiley   +1 more source

Clinical Characteristics of Sickle Cell Disease Patients with Leg Ulcer in Murtala Muhammad Specialist Hospital, Kano, Nigeria. [PDF]

Niger Med J
Borodo AM, Ibrahim UM, Ibrahim H.
europepmc   +1 more source

A New Fetal Hemoglobin-Related Phenotype in Sickle Cell Anemia. [PDF]

Am J Hematol
Steinberg MH, Rees DC.
europepmc   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; Spring 2021

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children

American Journal of Hematology, Volume 101, Issue 9, Page 2297-2310, September 2026.
ABSTRACT Hydroxyurea (HU) is the most widely prescribed disease‐modifying treatment in sickle cell disease (SCD), though treatment responses vary due to metabolism and adherence. We examined HU blood levels and treatment response in patients with homozygous sickle cell disease (HbSS).
Sigrid van der Veen, Bart J. Biemond, Marjon H. Cnossen, Pablo Bartolucci, Maria P. Boaro, Betzabel Cajiao Garcia, Raffaella Colombatti, M. D'Agnolo, Karin Fijnvandraat, Anna Collado Gimbert, Amira Idrizovic, Petros Kountouris, Mar Mañú‐Pereira, Elisabetta Mezzalira, Mariane de Montalembert, Erfan Nur, A. Pham Hung D' Alexandry D'Orengiani, Tiziana Sanavia, Saskia E. M. Schols, Marissa J. M. Traets, Minke A. E. Rab, Sara I. Reidel, Anita W. Rijneveld, Yosr Zaouali, Nanda M. Verhoeven‐Duif, Judith J. M. Jans, Eduard J. van Beers   +26 more
wiley   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; January 2022

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core